Shukra Pharmaceuticals Ltd — Insider Trade, 28-06-2025: Insider Trading / SAST

Shukra Pharmaceuticals has announced a closure of its trading window for promoters, directors, key management personnel, insiders, and their immediate relatives starting July 1 until 48 hours after the declaration of the financial results for the quarter ended June 30, 2025. This move ensures compliance with the company’s insider trading code and prevents any trading during sensitive periods, safeguarding shareholder interests. The date for the board meeting to approve the financial results will be shared later.